Literature DB >> 16722636

Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.

Rino Ragno1, Antonio Coluccia, Giuseppe La Regina, Gabriella De Martino, Francesco Piscitelli, Antonio Lavecchia, Ettore Novellino, Alberto Bergamini, Chiara Ciaprini, Anna Sinistro, Giovanni Maga, Emanuele Crespan, Marino Artico, Romano Silvestri.   

Abstract

Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of exceptionally potent indolyl aryl sulfones (IASs) characterized by the presence of either a pyrrolidyn-2-one nucleus at the indole-2-carboxamide or some substituents at the indole-2-carbohydrazide. Compounds 7 and 9 were found active in the sub-nanomolar range of concentration in both MT-4 and C8166 cell-based anti-HIV assays. These compounds, and in particular compound 9, also showed excellent inhibitory activity against both HIV-112 and HIV-AB1 primary isolates in lymphocytes and against HIV WT in macrophages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722636     DOI: 10.1021/jm0512490

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Gold(I)-Catalyzed Synthesis of 3-Sulfenyl Pyrroles and Indoles by a Regioselective Annulation of Alkynyl Thioethers.

Authors:  Peter E Simm; Prakash Sekar; Jeffery Richardson; Paul W Davies
Journal:  ACS Catal       Date:  2021-05-13       Impact factor: 13.084

2.  Synthesis of 3-sulfenyl- and 3-selenylindoles by the Pd/Cu-catalyzed coupling of N,N-dialkyl-2-iodoanilines and terminal alkynes, followed by n-Bu(4)NI-induced electrophilic cyclization.

Authors:  Yu Chen; Chul-Hee Cho; Feng Shi; Richard C Larock
Journal:  J Org Chem       Date:  2009-09-04       Impact factor: 4.354

3.  A novel synthetic route to 3-sulfenyl- and 3-selenylindoles by n-Bu4NI-induced electrophilic cyclization.

Authors:  Yu Chen; Chul-Hee Cho; Richard C Larock
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

4.  I2-Catalyzed sulfenylation of indoles and pyrroles using triethylammonium thiolates as sulfenylating agents.

Authors:  Wei Fan; Zhen Yang; Bo Jiang; Guigen Li
Journal:  Org Chem Front       Date:  2017-02-20       Impact factor: 5.281

5.  Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

Authors:  Ye Tian; Zhaoqiang Liu; Jinghan Liu; Boshi Huang; Dongwei Kang; Heng Zhang; Erik De Clercq; Dirk Daelemans; Christophe Pannecouque; Kuo-Hsiung Lee; Chin-Ho Chen; Peng Zhan; Xinyong Liu
Journal:  Eur J Med Chem       Date:  2018-03-23       Impact factor: 6.514

6.  Dual vicinal functionalisation of heterocycles via an interrupted Pummerer coupling/[3,3]-sigmatropic rearrangement cascade.

Authors:  Mindaugas Šiaučiulis; Selma Sapmaz; Alexander P Pulis; David J Procter
Journal:  Chem Sci       Date:  2017-11-17       Impact factor: 9.825

Review 7.  Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

Authors:  Valeria Famiglini; Romano Silvestri
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

8.  Copper-catalysed regioselective sulfenylation of indoles with sodium sulfinates.

Authors:  Xiaojun Luo; Qiang Liu; Hongxia Zhu; Huoji Chen
Journal:  R Soc Open Sci       Date:  2018-05-30       Impact factor: 2.963

Review 9.  Synthetic strategies, SAR studies, and computer modeling of indole 2 and 3-carboxamides as the strong enzyme inhibitors: a review.

Authors:  Gholamabbas Chehardoli; Asrin Bahmani
Journal:  Mol Divers       Date:  2020-05-12       Impact factor: 2.943

10.  A selenium-based ionic liquid as a recyclable solvent for the catalyst-free synthesis of 3-selenylindoles.

Authors:  Everton G Zimmermann; Samuel Thurow; Camilo S Freitas; Samuel R Mendes; Gelson Perin; Diego Alves; Raquel G Jacob; Eder J Lenardão
Journal:  Molecules       Date:  2013-04-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.